+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
CARERATING

CARE Ratings Share Price

 

 

CARE Ratings live price: ₹1,669.40. It opened at ₹1,676 vs previous close ₹1,673; intraday high/low: ₹1,694/₹1,660. The 50 & 200 DMA stand at ₹1,650.10/₹1,601.90.

CARE Ratings Performance

  • Today's Low
  • ₹1,660
  • Today's High
  • ₹1,694
  • 52 Week Low
  • ₹1,393
  • 52 Week High
  • ₹1,857
  • Open Price₹1,676
  • Previous Close₹1,673
  • Volume24,114
  • 50 DMA₹1,650.10
  • 100 DMA₹1,633.30
  • 200 DMA₹1,601.90

CARE Ratings Chart

Investment Returns

  • Over 1 Month + 1.79%
  • Over 3 Month + 6.22%
  • Over 6 Month + 3.43%
  • Over 1 Year -7.56%

Smart Investing Starts Here Start SIP with CARE Ratings for Steady Growth!

Invest Now

CARE Ratings Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 29.3
  • PEG Ratio
  • 1.2
  • Market Cap Cr
  • 5,023
  • P/B Ratio
  • 5.4
  • Average True Range
  • 47.8
  • EPS
  • 56.9
  • Dividend Yield
  • 1.3
  • MACD Signal
  • 3.1
  • RSI
  • 52.25
  • MFI
  • 59.82

Latest Stock News Updates

CARE Ratings Ltd - 534804 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

Allotment of 26,733 equity shares pursuant to exercise of ESOP

CARE Ratings Ltd - 534804 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018

CARE Ratings Ltd - 534804 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018

CARE Ratings Financials

CARE Ratings Technicals

EMA & SMA

Current Price
₹1,669.40
-3.8 (-0.23%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹1,659.40
  • 50 Day
  • ₹1,650.10
  • 100 Day
  • ₹1,633.30
  • 200 Day
  • ₹1,601.90

Resistance and Support

1674.4 Pivot Speed
  • R3 1,722.60
  • R2 1,708.20
  • R1 1,688.80
  • S1 1,655.00
  • S2 1,640.60
  • S3 1,621.20

CARE Ratings Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-13 Audited Results & Final Dividend
2026-02-11 Quarterly Results
2025-11-12 Quarterly Results & Interim Dividend
2025-08-05 Quarterly Results
2025-05-12 Audited Results & Final Dividend
Date Purpose Remarks
2026-06-26 FINAL Rs.14.00 per share(140%)Final Dividend
2025-11-19 INTERIM Rs.8.00 per share(80%)Interim Dividend
2025-06-27 FINAL Rs.11.00 per share(110%)Final Dividend
2024-11-05 INTERIM Rs.7.00 per share(70%)Interim Dividend
2024-06-21 FINAL Rs.11.00 per share(110%)Final Dividend
View CARE Ratings Dividend History Arrow

CARE Ratings Shareholding Pattern

45.01%
23.41%
17.9%
13.68%
0%

About CARE Ratings

CARE Ratings has commenced its operations in April 1993 and has established itself as the leading credit rating agency of India. The Company provides various credit ratings that helps corporates to raise capital for their various requirements and assists the investors to form an informed investment decision based on the credit risk and their own risk-return expectations. The Company has its registered office and head office both located in Mumbai. In addition, CARE Ratings has regional offices at Ahmedabad, Bengaluru, Chennai, Coimbatore, Hyderabad, Kolkata, Noida and Pune. View More
  • NSE Symbol
  • CARERATING
  • BSE Symbol
  • 534804
  • Managing Director,Group Chief Executive Officer
  • MEHUL HARSHADRAY PANDYA
  • ISIN
  • INE752H01013

Similar Stocks to CARE Ratings

CARE Ratings FAQs

CARE Ratings share price is ₹1,669 As on 18 July, 2026 | 01:44

The Market Cap of CARE Ratings is ₹5022.7 Cr As on 18 July, 2026 | 01:44

The P/E ratio of CARE Ratings is 29.3 As on 18 July, 2026 | 01:44

The PB ratio of CARE Ratings is 5.4 As on 18 July, 2026 | 01:44

The 52 week High & Low of CARE Ratings is ₹1857.2/₹1392.7 respectively As on 18 July, 2026 | 01:44

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23